Verona Pharma PLC ADR (VRNA NASDAQ) stock market data APIs
$104.326
1.09(1%)
as of July 10, 2025
Try our APIs with
free plan!
Verona Pharma PLC ADR Financial Data Overview
Price chart is built with
Anychart
Verona Pharma plc, a biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company offers Ohtuvayre, a dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that combines bronchodilator and non-steroidal anti-inflammatory effects for the maintenance treatment of chronic obstructive pulmonary disease, as well as cystic fibrosis and asthma. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom.
Prev. Close
104.326
Open
105.4137
High
104.3075
Low
104.6295
52 wk Range
18.51-104.99
Market Cap
8 910 M
Shares Outstanding
84 979 K
Revenue
119 M
EPS
-0.02
Beta
0.216
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Verona Pharma PLC ADR data using free add-ons & libraries
Get Verona Pharma PLC ADR Fundamental Data
Verona Pharma PLC ADR Fundamental data includes:
- Net Revenue: 119 M
- EBITDA: -133 641 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-25
- EPS/Forecast: -0.0325
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Verona Pharma PLC ADR News
New
Verona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck
Verona Pharma plc (NASDAQ:VRNA) is one of the 10 Stocks Going Wild. Verona Pharma surged by 20.62 percent on Wednesday to end at $104.77 per share following news that it was being acquired by US-bas...
Trump Says Powell’s Fed Job Is Easy. Why Nvidia, Bitcoin, Market Rally Say Otherwise and 5 Other Things to Know Today.
Federal Reserve officials split over when to cut rates, Brazil vows response to 50% tariff, and more news to start your day. Continue Reading View Comments
Piper Sandler Lifts PT on Verona Pharma (VRNA) Stock, Maintains Overweight
Verona Pharma plc (NASDAQ:VRNA) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. Piper Sandler increased the price target on the company’s stock to $160 from $76, wh...
Stocks Settle Higher on Tech Stock Strength and Lower Bond Yields
The S&P 500 Index ($SPX) (SPY) Wednesday closed up +0.61%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.49%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.72%. September E-min...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
